New Investor Libertatis Ergo Holding joins the financing round alongside existing investors FIRST Fund, KIKK Capital and Oost NLfunding to further progress its pipeline of cardiovascular disease targets, taking its total seed financing to €3.8 millionOver €2 million in non-dilutive grant funding from EIC (European Innovation Council) to enable the further advancement of its technology...Read More

We are pleased to announce that we have been granted €1.45 million from the EIC-Transition to bring our hiPSC-3D cardiac strips into a high throughput setting. In this project, we will miniaturize,  automate and scale-up the production of human 3D cardiac strips by combining 3D cardiac tissues derived from human induced pluripotent stem cell (hiPSC)...Read More

We are happy to announce that we have received a €4 Million grant from the EIC-Pathfinder Challenge. This grant will fund the development of a pumping human Mini-heart and swimming human Bio-Robot by a consortium composed of two companies, River BioMedics (RBM) and NanoScale Systems (Nanoss) GmbH and two universities, the University of Twente and Universidad de Málaga . The project will be...Read More

River BioMedics presented during the poster session of the European Organ-on-Chip Society (EUROoCS) 2021 conference as part of the collaboration with the Applied Stem Cell Technologies (AST) group, lead by Prof. Robert Passier from the University of Twente.Read More

River BioMedics was featured as one of the inventions emerging from the University of Twente. Read more in the interview with our Scientific Advisory Board member Prof. Albert van den Berg, in the local newspaper Tubantia!Read More

In an interview with the local newspaper Tubantia, we explain how we are building our 3D cardiac models and why our high-throughput technology is crucial to perform large drug screens for pharmaceutical companies.Read More